Invention Grant
- Patent Title: ErbB2 and ErbB3 chimeric heteromultimer adhesins
- Patent Title (中): ErbB2和ErbB3嵌合异源多聚体粘附素
-
Application No.: US10746176Application Date: 2003-12-22
-
Publication No.: US07659368B2Publication Date: 2010-02-09
- Inventor: Vincent Danial Fitzpatrick , Mark Sliwkowski , Richard L. Vandlen
- Applicant: Vincent Danial Fitzpatrick , Mark Sliwkowski , Richard L. Vandlen
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Arnold & Porter LLP
- Agent Jeffery P. Bernhardt
- Main IPC: C07K14/00
- IPC: C07K14/00 ; C07H21/02 ; C07H21/04 ; A61K39/00 ; A61K39/385 ; A61K48/00

Abstract:
Novel chimeric heteromultimer adhesins that bind the ligand of natural heteromultimeric receptors and uses therefor are disclosed. The chimeric molecules of the heteromultimer adhesins comprise an extracellular domain of a heteromultimeric receptor monomer and a multimerization domain for the stable interaction of the chimeric molecules in the adhesin. Specifically disclosed are heteromultimeric adhesins comprising the extracellular domains of ErbB2 and ErbB3 or ErbB2 and ErbB4. The chimeric ErbB heteromultimer adhesins of the present invention are useful as competitive antagonists or agonists of a neuregulin for the treatment of diseases such as various cancers.
Public/Granted literature
- US20040138417A1 Chimeric heteromultimer adhesins Public/Granted day:2004-07-15
Information query